Intraocular pressure fluctuations in response to the water-drinking provocative test in patients using latanoprost versus unoprostone

Journal of Ocular Pharmacology and Therapeutics

Volumn 20, Issue 5, 2004, Pages 401-410

  Susanna Jr , Remo ^a   Medeiros, Felipe A ^a,b,c   Vessani, Roberto M ^a   Giampani Jr , Jair ^a   Borges, Adriana S ^a   Jordão, Marcelo L S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LATANOPROST; UNOPROSTONE ISOPROPYL ESTER;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COVARIANCE; DRUG EFFICACY; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PARALLEL DESIGN; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; WATER LOADING;

ANTIHYPERTENSIVE AGENTS; DINOPROST; DOUBLE-BLIND METHOD; DRINKING; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; PROSTAGLANDINS F, SYNTHETIC; TONOMETRY, OCULAR; WATER;

EID: 7444246022     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2004.20.401     Document Type: Article

References (39)

1. Kidd, M.N., and O'Conner, M. Progression of fieid loss after trabeculectomy: A five-year follow-up. Br. J. Ophthalmol. 69:827-831, 1985.
2. Schulzer, M., Mikelberg, P.S., and Drance, S.M. Some observations on the relation between intraocular pressure and the progression of glaucomatous visual field loss. Br. J. Ophthalmol. 71:486-488, 1987.
3. O'Brien, C., Schwartz, B., Takamoto, T., et al. Intraocular pressure and the rate of visual field loss in chronic open-angle glaucoma. Am. J. Ophthalmol. 111:491-500, 1991.
4. Chauhan, B.C., and Drance, S.M. The relationship between intraocular pressure and visual field progression in glaucoma. Graefe's Arch. Clin. Exp. Ophthalmol. 230:521-526, 1992.
5. Drance, S.M. Diurnal variation of intraocular pressure in treated glaucoma. Arch. Ophthalmol. 70:302-311, 1963.
6. Zeimer, R.C., Wilensky, J.T., Gieser, D.R., et al. Association between intraocular pressure peaks and progression of visual field loss. Ophthalmology 98:64-69, 1991.
7. Katavisto, M. The diurnal variations of ocular tension in glaucoma. Acta Ophthalmol. 78(Suppl):1-131, 1964.
8. Jensen, A.D., and Maumenee, A.E. Home tonometry. Am. J. Ophthalmol. 76:929-932, 1973.
9. Zeimer, R.C., Wilensky, J.T., Gieser, D.R., et al. Application of a self-tonometer to home tonometry. Arch. Ophthalmol. 104:49-53, 1986.
10. Asrani, S., Zeimer, R., Wilensky, J., et al. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J. Glaucoma 9:134-142, 2000.
11. Miller, D. The relationship between diurnal tension variation and the water-drinking test. Am. J. Ophthalmol. 58:243-247, 1964.
12. Frankelson, E.N. The role of the water test in evaluation of glaucoma control. Canad. J. Ophthalmol. 9:408-410, 1974.
13. Helal, J. Contributions to the study of intraocular pressure: Peaks of intraocular pressure in the diurnal tension curve and in the water-drinking provocative test [in Spanish]. Rev. Bras. Oftal. 47:75-80, 1988.
14. Susanna, R., Medeiros, F.A., and Vessani, R.M. Correlation between intraocular pressure peaks in the diurnal tension curve and in the water-drinking test [ARVO Abstract]. Invest. Ophthalmol. Vis. Sci. 42:S558, 2001.
15. Medeiros, F.A., Leite, C.A., Correlation between intraoccular pressure peaks in the diurnal tension curve and in the water-drinking provocative test: A study in primary open-angle glaucoma patients using timolol and dorzolamide [in Spanish]. Rev. Bras. Oftal. 60:418-423, 2001.
16. Yoshikawa, K., Inohue, T., and Inohue, Y. Normal tension glaucoma: The value of predictive tests. Acta. Ophthalmol. 71:463-470, 1993.
17. Armaly, M.F., Krueger, D.E., Maunder, L., et al. Biostatistical analysis of the Collaborative Glaucoma Study. I. Summary report of the risk factors for glaucomatous visual-field defects. Arch. Ophthalmol. 98:2163-2171, 1980.
18. Chen, C.H., Lu, D.W., Chang, C.J., et al. The application of the water-drinking test on the evaluation of trabeculectomy patency. J. Ocular. Pharmacol. Ther. 16:37-42, 2000
19. Roth, J.A. Inadequate diagnostic value of the water-drinking test. Br. J. Ophthalmol. 58:55-61, 1974.
20. Brubaker, R.F. Importance of outflow facility. Int. Glaucoma Rev. 3(1):5, 2001.
21. Brubaker, R.F. Targeting outflow facility in glaucoma management. Surv. Ophthalmol. 48:S17-S20, 2003.
22. Susanna, R. Jr., and Medeiros, F.A. The pros and cons of different prostanoids in the medical management of glaucoma. Curr. Opinion Ophthalmol. 12:149-156, 2001.
23. Susanna, R. Jr., Chew, P., and Kitazawa, Y. Current status of prostaglandin therapy: Latanoprost and unoprostone. Surv. Ophthalmol. 47:S97-S104, 2002.
24. Jampel, H.D., Bacharach, J., Wang-Pui, S., et al. Randomized clinical trial of latanoprost and unoprostone in patients with elevated intraocular pressure. Am. J. Ophthalmol. 134:863-871, 2002.
25. Susanna, R. Jr., Giampani, J. Jr., Borges, A.S., et al. A double-masked, randomized, clinical trial comparing latanoprost with unoprostone in patients with open-angle glaucoma and ocular hypertension. Ophthalmology 108:259-263, 2001.
26. Aung, T., Chew, P.T.K., Yip, C-C., et al. A randomized, double-masked, crossover study comparing latanoprost 0.005% with unoprostone 0.12% in patients with primary open-angie glaucoma and ocular hypertension. Am. J. Ophthalmol. 131:636-642, 2001.
27. 2-α analogs, latanoprost, and unoprostone isopropyl. J. Glaucoma 10:487-492, 2001.
28. Saito, M., Takano, R., and Shirato, S. Effects of latanoprost and unoprostone when used alone or in combination for open-angle glaucoma. Am. J. Ophthalmol. 132:485-489, 2001.
29. Sponsel, W.E., Paris, G., Trigo, Y., et al. Comparative effects of latanoprost (Xalatan) and unoprostone (Rescula) in patients with open-angle glaucoma and suspected glaucoma. Am. J. Ophthalmol. 134:552-559, 2002.
30. Stewart, W.C., Chorak, R.P., Hunt, H.H., et al. Factors associated with visual-field loss in patients with advanced glaucomatous changes in the optic nerve head. Am. J. Ophthalmol. 116:176-181, 1993.
31. Ishida, K., Yamamoto, T., and Kitazawa, Y. Clinical factors associated with progression of normal-tension glaucoma. J. Glaucoma 7:372-377, 1998.
32. Brubaker, R.F. Goldmann's equation and clinical measures of aqueous dynamics. Exp. Eye Res. 78:633-637, 2004.
33. Alm, A., and Villumsen, J. PhXA34, a new potent ocular hypotensive drug: A study on dose-response relationship and on aqueous humor dynamics in healthy volunteers. Arch. Ophthalmol. 109:1564-1568, 1991.
34. Ziai, N., Dolan, J.W., Kacere, R.D., et al. The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analog, after topical application in normal and ocular hypertensive human subjects. Arch. Ophthalmol. 111:1351-1358, 1993.
35. Brubaker, R.F., Schoff, E.O., Nau, C.B., et al. Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics. Am. J. Ophthalmol. 131:19-24, 2001.
36. Sakurai, M., Araie, M., Oshika, T., et al. Effects of topical application of UF-021, a novel prostaglandin derivative, on aqueous humor dynamics in normal human eyes. Jpn. J. Ophthalmol. 35:156-165, 1991.
37. Martinez-Belló, C., Chauhan, B.C., Nicolela, M.T., et al. Intraocular pressure and progression of glaucomatous visual-field loss. Am. J. Ophthalmol. 129:302-308, 2000.
38. The AGIS investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual-field deterioration. Am. J. Ophthalmol. 130:429-440, 2000.
39. Medeiros, F.A., Pinheiro, A., Moura, F.C., et al. Intraocular pressure fluctuations in medical versus surgically treated glaucomatous patients. J. Ocul. Pharmacol. Ther. 18(6):489-498, 2002.